The Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) has voted to recommend that pediatric patients (2 to 18 years old) who have not previously received hepatitis A vaccine be routinely vaccinated at any age.
The new recommendation is being reviewed by the director of the CDC and the Department of Health and Human Services; the recommendation will become official once it is published in the CDC’s Morbidity and Mortality Weekly Report (MMWR).
Available hepatitis A vaccines include Havrix (GlaxoSmithKline) and Vaqta (Merck). Patients over the age of 18 may also receive Twinrix (GlaxoSmithKline), the combined hepatitis A and hepatitis B vaccine.
For more information visit cdc.gov.
This article originally appeared on MPR